文献速递乳房整形与再造显微修复重建

显微乳房再造术后住院皮瓣监测的简化成本-效用分析及住院时长启示

A Simplified Cost-Utility Analysis of Inpatient Flap Monitoring after Microsurgical Breast Reconstruction and Implications for Hospital Length of Stay.
PubMed 文献 · Plast Reconstr Surg · 2019-01-01

该研究基于1813例患者(2847个皮瓣)的回顾性数据库,分析显微乳房再造术后按天计算的皮瓣取回率与挽救率,并建立简化成本-效用模型。结果显示术后第2天起住院皮瓣监测的增量成本效果比开始超过10万美元/质量调整生命年的支付意愿阈值,提示术后第2天后监测成本快速上升。

要点

  • 术后第0-1天取回率56.8%、挽救率60.0%,第2天取回率13.6%、挽救率83.3%。
  • 术后第2天起住院皮瓣监测的增量成本效果比超过10万美元/质量调整生命年阈值。
  • 术后第2天需监测363个皮瓣才能挽救1个失败皮瓣,第3天需907个。

核心结论

  • 显微乳房再造术后住院皮瓣监测的医疗成本在术后第2天后开始快速上升。

研究设计与样本

  • 回顾性分析前瞻性维护数据库,纳入1813例患者共2847个皮瓣,计算按术后天数的皮瓣取回率与挽救率,并建立简化成本-效用模型。

主要发现

  • 总体皮瓣取回率为2.4%,挽救率为52.3%。
  • 取回皮瓣中,术后第0-1天取回率56.8%、挽救率60.0%;第2天取回率13.6%、挽救率83.3%;第3天取回率11.4%、挽救率40.0%;第4天取回率9.1%、挽救率25.0%;第4天以后取回率9.1%、挽救率0.0%。
  • 每日挽救1个失败皮瓣所需监测的皮瓣数:第0-1天121个,第2天363个,第3天907个,第4天1813个,第4天以后无法计数。
  • 住院皮瓣监测的增量成本效果比在术后第2天开始超过10万美元/质量调整生命年的支付意愿阈值。

关键数值与推荐

  • 术后第0-1天取回率56.8%、挽救率60.0%;第2天取回率13.6%、挽救率83.3%;第3天取回率11.4%、挽救率40.0%;第4天取回率9.1%、挽救率25.0%;第4天以后取回率9.1%、挽救率0.0%。
  • 每日挽救1个失败皮瓣需监测皮瓣数:第0-1天121个,第2天363个,第3天907个,第4天1813个,第4天以后无法计数。
  • 增量成本效果比在术后第2天开始超过10万美元/质量调整生命年阈值。

临床怎么用

  • 显微乳房再造术后应关注住院皮瓣监测的成本-效用,术后第2天后监测成本快速上升,可据此优化住院时长与监测资源配置。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The number of free flap take-backs and successful salvages following microsurgical breast reconstruction decreases as time from surgery increases. As a result, the cost of extended inpatient monitoring to achieve a successful flap salvage rises rapidly with each postoperative day. This study introduces a simplified cost-utility model of inpatient flap monitoring and identifies when cost-utility exceeds the thresholds established for other medical treatments. METHODS: A retrospective review of a prospectively maintained database was performed of patients who underwent microsurgical breast reconstruction to identify flap take-back and salvage rates by postoperative day. The number of patients and flaps that needed to be kept on an inpatient basis each day for monitoring to salvage a single failing flap was determined. Quality-of-life measures and incremental cost-effectiveness ratios for inpatient flap monitoring following microsurgical breast reconstruction were calculated and plotted against a $100,000/quality-adjusted life-year threshold. RESULTS: A total of 1813 patients (2847 flaps) were included. Overall flap take-back and salvage rates were 2.4 percent and 52.3 percent, respectively. Of the flaps taken back, the daily take-back and salvage rates were 56.8 and 60.0 percent (postoperative day 0 to 1), 13.6 and 83.3 percent (postoperative day 2), 11.4 and 40.0 percent (postoperative day 3), 9.1 and 25.0 percent (postoperative day 4), and 9.1 and 0.0 percent (>postoperative day 4), respectively. To salvage a single failing flap each day, the number of flaps that needed to be monitored were 121 (postoperative day 0 to 1), 363 (postoperative day 2), 907 (postoperative day 3), 1813 (postoperative day 4), and innumerable for days beyond postoperative day 4. The incremental cost-effectiveness ratio of inpatient flap monitoring begins to exceed a willingness-to-pay threshold of $100,000/quality-adjusted life-year by postoperative day 2. CONCLUSION: The health care cost associated with inpatient flap monitoring following microsurgical breast reconstruction begins to rise rapidly after postoperative day 2.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Jablonka EM, Lamelas AM, Kanchwala SK, et al. A Simplified Cost-Utility Analysis of Inpatient Flap Monitoring after Microsurgical Breast Reconstruction and Implications for Hospital Length of Stay. Plast Reconstr Surg. 2019. PMID: 31568278. doi:10.1097/PRS.0000000000006010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。